Giulia Pavia
Humanitas University(IT)IRCCS Humanitas Research Hospital(IT)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Dermatological and COVID-19 studies
Most-Cited Works
- → Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study(2021)45 cited
- → Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series(2023)41 cited
- → Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital(2021)40 cited
- → Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study(2022)36 cited
- → Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study(2021)34 cited
- → Brodalumab: A new way to inhibit IL ‐17 in psoriasis(2020)32 cited
- → Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population(2021)32 cited
- → Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study(2022)30 cited
- → Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID‐19 vaccine, successfully treated with risankizumab(2022)27 cited
- → A fatal case of COVID ‐19 infection presenting with an erythema multiforme‐like eruption and fever(2020)24 cited